INDUCTION THERAPY INCLUDING 131 I-MIBG AND CHEMOTHERAPY IN TREATING PATIENTS WITH NEWLY DIAGNOSED HIGH-RISK NEUROBLASTOMA UNDERGOING STEM CELL TRANSPLANT, RADIATION THERAPY, AND MAINTENANCE THERAPY WITH ISOTRETINOIN: